Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM Power Behind Pharmacogenomics: CVS Caremark Launching Program

Executive Summary

CVS Caremark is expanding its commitment to pharmacogenomics with a new clinical and testing services program being developed in collaboration with newly-formed Generation Health, which describes itself as a genetic benefits management company

You may also be interested in...



CVS Caremark, Generation Health Name 13 Drugs As Initial Focus Of Pharmacogenomics Partnership; Outline Testing Procedure

CVS Caremark, in partnership with Generation Health, announced the initial list of drugs that will be the focus of pharmacogenomic testing among clients of the pharmacy benefits manager, including six drugs dispensed through retail and mail-order pharmacies and seven distributed through specialty pharmacies

CVS Caremark, Generation Health Name 13 Drugs As Initial Focus Of Pharmacogenomics Partnership; Outline Testing Procedure

CVS Caremark, in partnership with Generation Health, announced the initial list of drugs that will be the focus of pharmacogenomic testing among clients of the pharmacy benefits manager, including six drugs dispensed through retail and mail-order pharmacies and seven distributed through specialty pharmacies

Deals Of The Week: GSK/Apeiron, Cephalon/Mepha, Medco/DNA Direct...

Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.

Related Content

Topics

UsernamePublicRestriction

Register

PS051675

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel